Anna De Ponti

NMS-P937, an Orally Available, Specific Small-Molecule Polo-like Kinase 1 Inhibitor with Antitumor Activity in Solid and Hematologic Malignancies

Barbara Valsasina, Italo Beria, Cristina Alli et al. · Molecular Cancer Therapeutics · 2012 · 119 citations · Full text

Bipolar Spindle Formation, Antitumor Activity, Cell Death +17

Identification of 4,5-Dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline Derivatives as a New Class of Orally and Selective Polo-Like Kinase 1 Inhibitors

Italo Beria, Dario Ballinari, J. A. Bertrand et al. · Journal of Medicinal Chemistry · 2010 · 80 citations · Full text

Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.

Ulisse Cucchi, Laura Gianellini, Anna De Ponti et al. · PubMed · 2010 · 62 citations

Molecular Regulation, Cell Death, Pathology +21

Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90)

Maria Gabriella Brasca, Sergio Mantegani, Nadia Amboldi et al. · Bioorganic & Medicinal Chemistry · 2013 · 33 citations · Full text

Protein Chemistry, Protein Function, Biochemistry +5

NMS-E973, a Novel Synthetic Inhibitor of Hsp90 with Activity against Multiple Models of Drug Resistance to Targeted Agents, Including Intracranial Metastases

Gianpaolo Fogliatto, Laura Gianellini, Maria Gabriella Brasca et al. · Clinical Cancer Research · 2013 · 26 citations